Organ support & nutrition

Effect of high versus standard protein provision on functional recovery in people with critical illness (PRECISe): an investigator-initiated, double-blinded, multicentre, parallel-group, randomised controlled trial in Belgium and the Netherlands

LancetPublished Randomised controlled trial

Primary result · EQ-5D-5L health utility score during 180 daysResult — go to the resultMean difference −0.05 95% CI −0.10 to −0.01

Authors' conclusion

High enteral protein provision compared with standard enteral protein provision resulted in worse health-related quality of life in critically ill patients and did not improve functional outcomes during 180 days after ICU admission.

Study context

Population
Critically ill adults on invasive mechanical ventilation started within 24 h of intensive care unit (ICU) admission, expected ventilation ≥3 days; five Dutch and five Belgian hospitalsrandomly assigned
Participants
935 adults
Comparison
High vs standard enteral protein provision
  • Standard proteinn = 465reference
  • High proteinn = 470
Primary endpoint
EQ-5D-5L health utility score, adjusted for baseline score
Follow-up
30, 90 and 180 days after randomisation
Methodological detailsinvestigator-initiated, double-blinded, multicentre, parallel-group
  • Investigator-initiated
  • Double-blinded
  • Multicentre
  • Parallel-group

Primary result

EQ-5D-5L health utility score during 180 days · 30, 90 and 180 days

Mean difference

−0.05

95% CI −0.10 to −0.01

P = 0.031

High protein vs Standard protein
mean difference −0.05 (95% CI −0.10 to −0.01); P = 0.031

As reported in the abstract

Further findings

Probability

OutcomeStandard proteinHigh proteinHR (95% CI)P value
Mortality during entire follow-up0.38 (SE 0.02)0.42 (SE 0.02)1.14 (0.92–1.40)P = 0.22

Safety

OutcomeOR (95% CI)P value
Symptoms of gastrointestinal intoleranceHigher incidence in high protein1.76 (1.06–2.92)P = 0.030

Other adverse events

Incidence did not differ between groups

Original publication

Effect of high versus standard protein provision on functional recovery in people with critical illness (PRECISe): an investigator-initiated, double-blinded, multicentre, parallel-group, randomised controlled trial in Belgium and the Netherlands. Lancet. Published 17 August 2024. doi:10.1016/s0140-6736(24)01304-7

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.